Non-members: Click here to review a complimentary excerpt from "Resourcing a Successful Product Launch: Staffing Allocations"
The biopharmaceutical launch landscape is characterized by growing competition in the market and tighter resources for pre-launch activities. Launching a new product in such a complex environment requires meticulous resource planning from the pre-launch phase to beyond market entry.
To help biopharma leaders develop competitive staffing targets for launch and pre-launch activities, Best Practices, LLC conducted benchmarking research that probed current staffing allocations across the key activities required for a successful drug launch.
In particular, the study benchmarks the FTE allocation for 12 key promotional, educational and market-access activities for the launch year and the three years preceding launch. The study also assesses the investment ratios by FTEs and outlines the success factors for launching a new pharmaceutical product.
Launch and brand leaders can use this research to compare their staffing levels for pre-launch and launch activities with current benchmark from industry peers.
This study includes staffing segments for: Peak revenue; drug type; launch year; product position; and oncology therapeutic area.
Among all the listed activities, sales field force activities receive highest staffing during launch year and launch year -1.
Sixty-four percent of the benchmark participants consider market access and reimbursement as the most important success factor in establishing and allocating new product launch budgets.